
|Articles|June 24, 2009
Gene therapies
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma.
Advertisement
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma. In the Survey of Ophthalmology (Vol 54, No 4) Xuyanf Lie et al., look at Gene Therapy Targeting Glaucoma: Where Are We? and concludes: "Improvements in gene delivery techniques, refinement of vector construction methods, and development of better animal models combine to bring this potential therapy closer to reality."
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia
2
The interplay between cardiac disease and the eye
3
City Therapeutics doses first participant in phase 1 trial of RNAi therapy CITY-RBP4 for Stargardt disease
4
Longer anti-VEGF intervals in AMD, BRVO, and DME: 3 clinical cases
5
















